VI Ventures Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
7
- Investments
-
56
- Portfolio
-
26
- Exits
-
26
VI Ventures General Information
Company Description
Founded in 2012, VI Ventures is a venture capital firm headquartered in Hong Kong. The firm seeks to invest in the medtech sector. The firm prefers to invest in companies based in Asia.
Business Details
Website
www.en.vi-ventures.comYear Founded
Investor Status
Primary Investor Type
Other Investor Types
Corporate Office
- Suite 7013, 70F
- Two International Finance Centre, Central
- Hong Kong
- Hong Kong
VI Ventures Investments (56)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| AxCel Technology | 01-Mar-2023 | Later Stage VC | IT Consulting and Outsourcing | Generating Revenue | ||
| Metagenomi Therapeutics | 05-Jan-2023 | Drug Discovery | Generating Revenue | |||
| Biovision (Drug Discovery) | 01-Jul-2022 | Drug Discovery | Generating Revenue | |||
| WhiteSwell | 24-Jun-2022 | Therapeutic Devices | Clinical Trials - Phase 2 | |||
| Design Pharma | 12-Apr-2022 | Drug Discovery | Out of Business | |||
| ACXEL | 16-Nov-2021 | Other Healthcare Technology Systems | Generating Revenue | |||
| Base Therapeutics | 26-Jul-2021 | Discovery Tools (Healthcare) | Generating Revenue | |||
| Tyligand Bioscience | 19-Apr-2021 | Drug Discovery | Generating Revenue | |||
| Fresh Wind Biotechnologies | 13-Nov-2020 | Early Stage VC | Drug Discovery | Startup | ||
| Yizhen Intelligence | 19-Aug-2020 | Early Stage VC | Practice Management (Healthcare) | Generating Revenue |
VI Ventures Exits (26)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| StoreDot | 01-Jul-2026 | Secondary Transaction - Private | |
| Colospan | 22-Jun-2026 | ||
| Design Pharma | 09-Jun-2026 | ||
| HealthWatch | 01-May-2026 | ||
| HaoStay | 27-May-2024 | ||
| Metagenomi Therapeutics | 09-Feb-2024 | ||
| PlateletBio | 02-Dec-2023 | ||
| Applied StemCell | 09-Oct-2023 | ||
| Apexigen | 01-Aug-2022 | Reverse Merger | |
| IceCure Medical | 10-Dec-2021 | Public Investment 2nd Offering |
VI Ventures Investments by Industry, Year, and Region
VI Ventures Co-Investors (25)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Bristol-Myers Squibb | 1 |
|
|
||
| Farallon Capital Management |
|
|
|||
| Frazier Healthcare Partners |
|
|
|||
| Novo Holdings |
|
|
|||
| Piper Sandler |
|
|
VI Ventures FAQs
-
What is VI Ventures?
Founded in 2012, VI Ventures is a venture capital firm headquartered in Hong Kong.
-
When was VI Ventures founded?
VI Ventures was founded in 2012.
-
Where is VI Ventures headquartered?
VI Ventures is headquartered in Hong Kong, Hong Kong.
-
How many investments has VI Ventures made?
VI Ventures has made 56 investments.
-
What has VI Ventures invested in?
VI Ventures has made numerous investments in companies like AxCel Technology, Metagenomi Therapeutics, and Biovision (Drug Discovery) within the IT Consulting and Outsourcing and Drug Discovery industries.
-
What has VI Ventures invested in recently?
VI Ventures's latest investment was on 01-Mar-2023 in AxCel Technology, a company within the IT Consulting and Outsourcing industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process